Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027765
Disease: nervous system disorder
nervous system disorder
0.010 Biomarker group BEFREE The three classical MAPK subfamilies, extracellular signal-regulated kinase 1 and 2 (ERK1/2), c-Jun N-terminal kinase (JNK), and p38 kinase have been linked to various neurological disorders often in conjunction with activation of a wide range of G protein-coupled receptors and receptor tyrosine kinases. 30983972 2019
CUI: C0029456
Disease: Osteoporosis
Osteoporosis
0.010 Biomarker disease BEFREE Taken together, these results suggest that TAT-TN13 inhibits osteoclast differentiation by regulating the p38 and NF-κB signaling pathway; thus, it may be a useful agent for preventing or treating osteoporosis. 30934850 2019
CUI: C0030305
Disease: Pancreatitis
Pancreatitis
0.010 Biomarker disease BEFREE Inhibition of p38 activation resulted in alleviated pancreatitis. 31432106 2019
CUI: C0031069
Disease: Familial Mediterranean Fever
Familial Mediterranean Fever
0.010 Biomarker disease BEFREE Based on preliminary data by our group suggesting an upregulation of the mitogen-activated protein kinases (MAPKs) in human lymphocytes exposed to dabrafenib and trametinib, specifically elevated expression of phosphorylated JNK (p-JNK), p38 MAPK (p-p38 MAPK), and ERK5 (p-ERK5), we hypothesized that the mechanism of MAPK pathway activation with DT therapy is similar to that reported in patients with familial Mediterranean fever (FMF), a rare, inherited condition characterized by episodes of fever and rash that responds exceedingly well to colchicine-based therapy in which the MAPK pathway is hyper-activated. 30767130 2019
CUI: C0031117
Disease: Peripheral Neuropathy
Peripheral Neuropathy
0.010 PosttranslationalModification group BEFREE Collectively these data suggest that spinal P450c17 activates astrocytes via p38 phosphorylation, ultimately leading to the development of mechanical allodynia in a model of peripheral neuropathy. 31387001 2019
CUI: C0032000
Disease: Pituitary Adenoma
Pituitary Adenoma
0.010 Biomarker disease BEFREE The combined use of ERK inhibitor (e.g., SOM230, OCT, or dopamine) plus p38 activator (e.g., cabergoline, bromocriptine, and fulvestrant) and/or JNK activator (e.g., UA), or the development of single drug (e.g., BIM-23A760) to target both ERK and p38 or JNK pathways, might produce better anti-tumor effects on PAs. 31231308 2019
CUI: C0038013
Disease: Ankylosing spondylitis
Ankylosing spondylitis
0.010 AlteredExpression disease BEFREE Despite the lower basal expression of TLRs, AS-MSCs were as sensitive or more sensitive to TLR agonists as compared with HD-MSCs in terms of activation of p38 and ERK MAPK signaling pathways. 31456484 2019
CUI: C0038220
Disease: Status Epilepticus
Status Epilepticus
0.010 Biomarker disease BEFREE Roscovitine Attenuates Microglia Activation and Monocyte Infiltration via p38 MAPK Inhibition in the Rat Frontoparietal Cortex Following Status Epilepticus. 31331032 2019
CUI: C0038443
Disease: Stress, Psychological
Stress, Psychological
0.010 Biomarker disease BEFREE β-Endorphin Induction by Psychological Stress Promotes Leydig Cell Apoptosis through p38 MAPK Pathway in Male Rats. 31623282 2019
CUI: C0040100
Disease: Thymoma
Thymoma
0.010 AlteredExpression disease BEFREE In experimental models of disease, the carotenoid astaxanthin has been shown to modulate autophagy by regulating signaling pathways, including the AMP-activated protein kinase (AMPK), cellular homolog of murine thymoma virus akt8 oncogene (Akt), and mitogen-activated protein kinase (MAPK), such as c-Jun N-terminal kinase (JNK) and p38. 31547619 2019
CUI: C0041341
Disease: Tuberous Sclerosis
Tuberous Sclerosis
0.010 GeneticVariation disease BEFREE Accompanying this improvement was correction of activity in the p38 MAPK-TSC-Rheb-mTORC1-S6K1 pathway. 30928642 2019
CUI: C0041956
Disease: Ureteral obstruction
Ureteral obstruction
0.010 PosttranslationalModification phenotype BEFREE In a mouse UUO model, renal protein expression of COL1 and phosphorylated p38 were significantly increased, and the protein expression of COL1 and phosphorylated p38 decreased in mice administered 10 mg/kg/day p38 MAPK inhibitor. 30897126 2019
CUI: C0079744
Disease: Diffuse Large B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
0.010 AlteredExpression disease BEFREE Newly formed NETs directly upregulated the Toll-like receptor 9 (TLR9) pathways in DLBCL and subsequently activated NFκB, STAT3, and p38 pathways to promote tumor progression. 30446590 2019
CUI: C0149630
Disease: Bicuspid aortic valve
Bicuspid aortic valve
0.010 AlteredExpression disease BEFREE The senescent-collagenolytic SMC phenotype depended on p38 MAPK signaling, which was chronically activated in BAV aortas. 31078518 2019
CUI: C0151565
Disease: Hemorrhagic colitis
Hemorrhagic colitis
0.010 Biomarker disease BEFREE Enterohemorrhagic <i>Escherichia coli</i> (EHEC) is a pathological strain that can induce mitogen-activated protein (MAP) kinase (Erk, Jnk and p38 MAPK) and NF-κB pathway activation and proinflammatory cytokine production, which then causes diarrheal diseases such as hemorrhagic colitis and hemolytic uremic syndrome. 31130074 2019
CUI: C0162309
Disease: Adrenoleukodystrophy
Adrenoleukodystrophy
0.010 PosttranslationalModification disease BEFREE GME attenuated ALD through inhibiting the phosphorylation of JNK and P38 and further suppressing the initiation of inflammation. 30298517 2019
CUI: C0162871
Disease: Aortic Aneurysm, Abdominal
Aortic Aneurysm, Abdominal
0.010 AlteredExpression disease BEFREE Inhibition of Iars significantly reduced the incidence of angiotensin II (AngII)-induced AAA in mice, coincident with decreased activity of the p38 MAPK pathway and increased PI3K pathway activity. 30905780 2019
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 AlteredExpression disease BEFREE Moreover, SATB1 expression and anoikis resistance were mainly regulated by HBV-encoded viral protein HBx through the activation of ERK and p38 MAPK signaling pathways to promote metastasis of liver cancer. 31147803 2019
Muscular Dystrophy, Facioscapulohumeral
0.010 Biomarker disease BEFREE We propose p38 inhibition as a disease-modifying therapeutic strategy for FSHD. 31189728 2019
CUI: C0267797
Disease: Acute hepatitis
Acute hepatitis
0.010 GeneticVariation disease BEFREE In this study, we found that a mutation of alternative p38 in mice augmented the severity of acute liver inflammation. 31780731 2019
CUI: C0276279
Disease: Mink parvovirus infection
Mink parvovirus infection
0.010 AlteredExpression disease BEFREE Taken together, our results demonstrated that MEV induces apoptosis through activation of p38 MAPK and the p53-mediated mitochondrial apoptotic pathway induced by NS1 protein, which sheds light on the molecular pathogenesis of MEV infection.<b>IMPORTANCE</b> MEV causes fatal hemorrhagic enteritis in minks. 31484746 2019
CUI: C0278147
Disease: Radicular pain
Radicular pain
0.010 AlteredExpression phenotype BEFREE Spinal SFKs contribute to radicular pain by activation of p38 MAPK and increasing pro-inflammatory cytokines expression in rats with NP implantation. 31261268 2019
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 AlteredExpression disease BEFREE Moreover, SATB1 expression and anoikis resistance were mainly regulated by HBV-encoded viral protein HBx through the activation of ERK and p38 MAPK signaling pathways to promote metastasis of liver cancer. 31147803 2019
CUI: C0345904
Disease: Malignant neoplasm of liver
Malignant neoplasm of liver
0.010 AlteredExpression disease BEFREE Moreover, SATB1 expression and anoikis resistance were mainly regulated by HBV-encoded viral protein HBx through the activation of ERK and p38 MAPK signaling pathways to promote metastasis of liver cancer. 31147803 2019
CUI: C0393591
Disease: AICARDI-GOUTIERES SYNDROME
AICARDI-GOUTIERES SYNDROME
0.010 Biomarker disease BEFREE Notably, DRP1 knockdown or SB203580-induced p38 inhibition reduced indomethacin-induced damage to AGSs. 30940726 2019